Before visiting, please review our current visitor policies and COVID-19 information.
ADVENT-IDE
Trial Overview
Official Title
A Prospective Randomized Pivotal Trial of the FARAPULSE Pulsed Field Ablation System Compared With Standard of Care Ablation in Patients With Paroxysmal Atrial Fibrillation
Study Purpose
This is a prospective, adaptive, multi-center, randomized safety and effectiveness pivotal study comparing the FARAPULSE Pulsed Field Ablation System with standard of care ablation with force-sensing RF catheters and cryoballoon catheters indicated for the treatment of PAF.
Diagnosis
Atrial FibrillationEligibility
Inclusion Criteria
- atrial fibrillation
- failed drug treatment
Exclusion Criteria
- Left ventricular ejection fraction < 40%
- Implantable cardiac devices
- Heart surgery or stroke within 6 months of enrollment
- Renal impairment
- Body mass index greater than 40
Intervention
FARAPULSE Pulsed Field Ablation System
For more information, visit the U.S. National Library of Medicine clinical trial database.
Key Participation Requirements
Trial Location(s)
Gender
Male or Female
Age
18 to 75
Enrollment Status
Active, Not Recruiting
Phase
Not Applicable
Methodist Health System Trial Code
NCT04612244